120 related articles for article (PubMed ID: 25939703)
1. JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.
Su CL; Deng TR; Shang Z; Xiao Y
Int J Hematol; 2015 Jul; 102(1):76-85. PubMed ID: 25939703
[TBL] [Abstract][Full Text] [Related]
2. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
Wang X; Lyu J; Ji A; Zhang Q; Liao G
Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
[TBL] [Abstract][Full Text] [Related]
3. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.
Adhikari A; Mainali P; Davie JK
J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284
[TBL] [Abstract][Full Text] [Related]
4. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
[TBL] [Abstract][Full Text] [Related]
5. Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
Zhu XX; Yan YW; Ai CZ; Jiang S; Xu SS; Niu M; Wang XZ; Zhong GS; Lu XF; Xue Y; Tian S; Li G; Tang S; Jiang YZ
Oncotarget; 2017 Apr; 8(15):24483-24490. PubMed ID: 28445934
[TBL] [Abstract][Full Text] [Related]
6. The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
Kuang W; Jiang W; Chen Y; Tian Y; Liu Z
Cancer Biol Ther; 2021 Jun; 22(5-6):392-403. PubMed ID: 34251962
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
8. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
9. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.
Celik H; Koh WK; Kramer AC; Ostrander EL; Mallaney C; Fisher DAC; Xiang J; Wilson WC; Martens A; Kothari A; Fishberger G; Tycksen E; Karpova D; Duncavage EJ; Lee Y; Oh ST; Challen GA
Cancer Cell; 2018 Nov; 34(5):741-756.e8. PubMed ID: 30423295
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
11. Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome.
da Rocha ST; Boeva V; Escamilla-Del-Arenal M; Ancelin K; Granier C; Matias NR; Sanulli S; Chow J; Schulz E; Picard C; Kaneko S; Helin K; Reinberg D; Stewart AF; Wutz A; Margueron R; Heard E
Mol Cell; 2014 Jan; 53(2):301-16. PubMed ID: 24462204
[TBL] [Abstract][Full Text] [Related]
12. Human RAD6 promotes G1-S transition and cell proliferation through upregulation of cyclin D1 expression.
Cai F; Chen P; Chen L; Biskup E; Liu Y; Chen PC; Chang JF; Jiang W; Jing Y; Chen Y; Jin H; Chen S
PLoS One; 2014; 9(11):e113727. PubMed ID: 25409181
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma.
Li Z; Li X; Li C; Su Y; Fang W; Zhong C; Ji W; Zhang Q; Su C
Cancer Lett; 2014 Nov; 354(1):77-86. PubMed ID: 25128069
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract][Full Text] [Related]
15. miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2.
Liang D; Li J; Wu Y; Zhen L; Li C; Qi M; Wang L; Deng F; Huang J; Lv F; Liu Y; Ma X; Yu Z; Zhang Y; Chen YH
Int J Cardiol; 2015 Dec; 201():38-48. PubMed ID: 26298346
[TBL] [Abstract][Full Text] [Related]
16. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
[TBL] [Abstract][Full Text] [Related]
17. Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1.
Zhang J; Roberts JM; Chang F; Schwakopf J; Vetter ML
Cell Rep; 2023 Mar; 42(3):112237. PubMed ID: 36924502
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
20. Autoregulation of JARID2 through PRC2 interaction with its antisense ncRNA.
Al-Raawi D; Kanhere A
BMC Res Notes; 2020 Oct; 13(1):501. PubMed ID: 33126912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
